These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 7530950)

  • 1. The use of wallstents in patients with benign prostatic hyperplasia.
    Guazzoni G; Montorsi F; Rigatti P
    Arch Esp Urol; 1994 Nov; 47(9):927-31. PubMed ID: 7530950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 12-year outcome analysis of an endourethral wallstent for treating benign prostatic hyperplasia.
    Masood S; Djaladat H; Kouriefs C; Keen M; Palmer JH
    BJU Int; 2004 Dec; 94(9):1271-4. PubMed ID: 15610103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy and complications of intraprostatic prosthesis in the treatment of benign hyperplasia of the prostate].
    Clemente Ramos L; Burgos Revilla FJ; Fernández Fernández E; Jiménez Cidre M; Cruz Guerra N; Escudero Barrilero A
    Arch Esp Urol; 1997 Sep; 50(7):773-80. PubMed ID: 9412383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Benign prostatic hyperplasia: five year follow-up in patients who underwent contact laser vaporization].
    Vela Navarrete R; García Cardoso JV; Calahorra Fernández FJ; Rodríguez Miñón JL; Cabrera Pérez J; González Enguita C
    Arch Esp Urol; 2004 Mar; 57(2):131-4. PubMed ID: 15074782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of benign prostatic hyperplasia in high risk patients: long-term experience with the Memotherm stent.
    Gesenberg A; Sintermann R
    J Urol; 1998 Jul; 160(1):72-6. PubMed ID: 9628608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the transurethral ethanol ablation of the prostate (TEAP) for symptomatic benign prostatic hyperplasia (BPH): a European multi-center evaluation.
    Grise P; Plante M; Palmer J; Martinez-Sagarra J; Hernandez C; Schettini M; Gonzalez-Martin M; Castiñeiras J; Ballanger P; Teillac P; Rolo F; Baena V; Erdmann J; Mirone V
    Eur Urol; 2004 Oct; 46(4):496-501; discussion 501-2. PubMed ID: 15363567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcome of prostatic stent treatment for benign prostatic hyperplasia.
    Chiou RK; Chen WS; Akbari A; Foley S; Lynch B; Taylor RJ
    Urology; 1996 Oct; 48(4):589-93. PubMed ID: 8886065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostatic UroLume Wallstent for benign prostatic hyperplasia patients at poor operative risk: clinical, uroflowmetric and ultrasonographic patterns.
    Guazzoni G; Bergamaschi F; Montorsi F; Consonni P; Galli L; Matozzo V; Rigatti P
    J Urol; 1993 Nov; 150(5 Pt 2):1641-6; discussion 1646-7. PubMed ID: 7692102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [How to plan the treatment of prostatic adenoma today?].
    Chatelain C; Conort P; Chartier-Kastler E; Boyer C; Bianchini JM; Richard F
    Bull Acad Natl Med; 1999; 183(3):615-34; discussion 634-7. PubMed ID: 10437290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term study to assess the efficacy of tamsulosin in the control of symptoms and complications developed in patients with symptomatic benign prostatic hyperplasia (OMNICONTROL study): first-year follow-up report.
    Palacio A; Hernández C; Marqués A; Prats J; Espinosa FJ
    Arch Esp Urol; 2004 May; 57(4):451-60. PubMed ID: 15270291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostatic stents for the treatment of benign prostatic hyperplasia.
    Vanderbrink BA; Rastinehad AR; Badlani GH
    Curr Opin Urol; 2007 Jan; 17(1):1-6. PubMed ID: 17143103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interstitial laser coagulation for management of benign prostatic hyperplasia: long-term follow-up.
    Terada N; Arai Y; Okubo K; Ichioka K; Matsui Y; Yoshimura K; Terai A
    Int J Urol; 2004 Nov; 11(11):978-82. PubMed ID: 15509201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photoselective vaporization of the prostate in the treatment of benign prostatic hyperplasia.
    Fu WJ; Hong BF; Yang Y; Cai W; Gao JP; Wang CY; Wang XX
    Chin Med J (Engl); 2005 Oct; 118(19):1610-4. PubMed ID: 16232345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of UroLume as an alternative to the treatment of recurrent stenosis of bulbar urethra and obstructive prostatic hyperplasia in patients with high surgical risk].
    Serrano-Brambila EA; Camacho-Carvajal JC; Moreno-Aranda J; Martínez-Sánchez R
    Gac Med Mex; 2003; 139(5):435-48. PubMed ID: 14635562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term results of contact laser versus transurethral resection of the prostate in the treatment of benign prostatic hyperplasia with small or moderately enlarged prostates.
    Tuhkanen K; Heino A; Aaltomaa S; Ala-Opas M
    Scand J Urol Nephrol; 2003; 37(6):487-93. PubMed ID: 14675922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of transrectal hyperthermia, transurethral thermotherapy, urolume wallstent, and prostatic spiral for benign prostatic hyperplasia patients at poor operative risk.
    Montorsi F; Guazzoni G; Bergamaschi F; Consonni P; Galli L; Rigatti P
    Prostate; 1994; 24(3):156-61. PubMed ID: 7509486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaporesection for managing benign prostatic hyperplasia using a 2-microm continuous-wave laser: a prospective trial with 1-year follow-up.
    Fu WJ; Hong BF; Yang Y; Zhang X; Gao JP; Zhang L; Wang XX
    BJU Int; 2009 Feb; 103(3):352-6. PubMed ID: 18778340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of greenlight photoselective vaporization of the prostate for the treatment of high-risk patients with benign prostatic hyperplasia.
    Fu WJ; Hong BF; Wang XX; Yang Y; Cai W; Gao JP; Chen YF; Zhang CE
    Asian J Androl; 2006 May; 8(3):367-71. PubMed ID: 16625289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transurethral resection of the prostate (TURP)--in the treatment of benign prostatic hypertrophy (BPH) in Mekelle, Ethiopia.
    Alemu MH
    Ethiop Med J; 2009 Jan; 47(1):65-9. PubMed ID: 19743783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostatic spiral versus prostatic urolume wallstent for urinary retention due to benign prostatic hyperplasia. A long-term comparative study.
    Guazzoni G; Montorsi F; Bergamaschi F; Consonni P; Bellinzoni P; Rigatti P
    Eur Urol; 1993; 24(3):332-6. PubMed ID: 7505225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.